Cocaine Intoxication Market Intelligence Report 2026: Industry Poised for Innovation as Unmet Treatment Needs and Rising Emergency Presentations Drive Demand
Dublin, Sept. 09, 2026 (GLOBE NEWSWIRE) -- The "Cocaine Intoxication - Market Insight, Epidemiology, and Market Forecast - 2036" has been added to ResearchAndMarkets.com's offering.
The cocaine intoxication market across the seven major markets-the United States, Germany, France, Italy, Spain, the United Kingdom, and Japan-was valued at approximately USD 130 million in 2025. According to market analysis, the sector is expected to expand at a compound annual growth rate of approximately 21% from 2026 to 2036, driven by increasing emergency department utilization, growing awareness of cocaine-related toxicity, and demand for more effective targeted therapies.
The report, Cocaine Intoxication - Market Insights, Epidemiology and Market Forecast - 2036, provides a comprehensive assessment of historical and forecast epidemiology, treatment practices, patient burden, market dynamics, therapy uptake, competitive activity, and commercial opportunities across the 7MM. It also examines market size and growth trends from 2022 through 2036.
Rising Emergency Department Burden Supports Market Growth
Cocaine intoxication continues to place substantial pressure on emergency and acute care systems. The report estimates that cocaine-related emergency department visits across the 7MM reached approximately 1 million in 2025 and will continue increasing during the forecast period. The United States accounted for the highest burden, with approximately 502,000 treated emergency department cases in 2025, while Japan recorded about 121,000 cocaine-related emergency visits.
Cardiovascular disease, psychiatric disorders, polysubstance use involving alcohol or opioids, and infectious diseases contribute significantly to the clinical burden. Cardiovascular complications represent a particularly important source of morbidity and mortality, reinforcing the need for early identification, continuous monitoring, integrated care, and improved intervention strategies.
Current Cocaine Intoxication Treatment Landscape
Clinical management remains predominantly supportive and symptom focused. Benzodiazepines, including lorazepam and diazepam, account for a substantial share of pharmacological treatment because of their use in managing agitation, seizures, tachycardia, hypertension, and sympathetic overactivity. Antipsychotic agents may be administered in selected cases involving severe agitation, hallucinations, psychosis, or delirium.
Cardiovascular management may include vasodilators, calcium channel blockers, antiarrhythmic agents, intravenous fluids, and continuous cardiac monitoring based on the patient's clinical presentation. External cooling is an important component of care for cocaine-associated hyperthermia, while advanced interventions may be required for serious ventricular arrhythmias and other life-threatening complications.
After acute stabilization and inpatient care, behavioral support, counseling, mental health services, and structured aftercare can help reduce relapse risk. Continued engagement, abstinence-focused behaviors, and improved self-efficacy are associated with better long-term outcomes.
Significant Unmet Need for Targeted Cocaine Intoxication Therapies
No pharmacological antidote is currently approved specifically for cocaine intoxication or overdose. Existing care relies on off-label medicines, supportive interventions, and treatment of individual complications. Major unmet needs include targeted toxin-neutralizing therapies, improved control of cocaine-induced agitation and delirium, and more effective management of cardiovascular and neurological toxicity.
The development pipeline remains limited, with research activity focused more heavily on cocaine use disorder than acute intoxication. In May 2025, Tonix Pharmaceuticals terminated the Phase II CATALYST study of TNX-1300 because of slow patient enrollment rather than safety or efficacy concerns. The company has indicated that revised study designs and endpoints may be explored.
Potential future approaches include cocaine esterases, enzyme-based therapies, monoclonal antibodies, and other interventions designed to accelerate cocaine metabolism or neutralize toxicity. These strategies could shift the market from symptom management toward mechanism-based treatment, potentially reducing severe complications, hospitalization, and mortality.
Cocaine Intoxication Market Outlook and Commercial Opportunities
The United States is expected to remain the largest cocaine intoxication market because of its higher cocaine-use burden, substantial emergency department utilization, established healthcare infrastructure, and investment in addiction and toxicology research. Germany, France, Italy, Spain, the United Kingdom, and Japan have lower reported burdens but are experiencing improvements in awareness, diagnosis, harm-reduction programs, and standardized emergency response protocols.
Market expansion is expected to be supported by increasing public health awareness, stronger emergency care infrastructure, greater recognition of polysubstance-related complications, and continued interest in rapid detoxification technologies. The absence of an approved targeted therapy creates a substantial opportunity for developers capable of addressing acute central nervous system and cardiovascular toxicity.
Report Coverage
Strategic Value of the Cocaine Intoxication Market Report
The report uses epidemiology-based, bottom-up forecasting to assess the relationship between patient burden, treatment utilization, and commercial potential. It provides actionable intelligence for pharmaceutical companies, biotechnology developers, investors, healthcare organizations, and other stakeholders evaluating the cocaine intoxication therapeutics market.
Expert insights from clinicians, researchers, professors, and other specialists across the 7MM support the analysis of treatment adoption, accessibility, patient adherence, prescribing patterns, and pipeline priorities. The findings can assist organizations in refining clinical development plans, identifying geographic opportunities, evaluating future competition, and preparing market access and launch strategies.
Overall, the cocaine intoxication market remains underdeveloped but commercially significant. Rising emergency presentations, persistent clinical complications, and the lack of approved targeted treatments are expected to sustain demand for innovation. Successful therapies that rapidly neutralize cocaine toxicity, improve stabilization, and reduce cardiovascular or neurological complications could materially reshape the treatment landscape through 2036.
Key Topics Covered
1. Key Insights
2. Report Introduction
3. Executive Summary of Cocaine Intoxication
4. Key Events
4.1. Upcoming Key Catalysts
4.2. Key Transactions And Collaborations
4.3. News Flow
5. Epidemiology and Market Forecast Methodology of Cocaine Intoxication
6. Cocaine Intoxication Market Overview at a Glance
6.1. Emerging Landscape Analysis (By Phase, Molecule Type, and RoA)
6.2. Market Share (%) Distribution of Cocaine Intoxication by Therapies in the 7MM, in 2025
6.3. Market Share (%) Distribution of Cocaine Intoxication by Therapies in the 7MM, in 2036
7. Disease Background and Overview of Cocaine Intoxication
7.1. Introduction
7.2. Signs and Symptoms of Cocaine Intoxication
7.3. Causes of Cocaine Intoxication
7.4. Risk factors of Cocaine Intoxication
7.5. Pathophysiology of Cocaine Intoxication
7.6. Diagnosis of Cocaine Intoxication
7.6.1. Differential Diagnosis
7.6.2. Diagnostic Algorithm of Cocaine Intoxication
8. Treatment
8.1. Algorithm for the Treatment of Cocaine Intoxication
8.2. Guidelines for the Treatment of Cocaine Intoxication
9. Epidemiology and Patient Population of Cocaine Intoxication
9.1. Key Findings
9.2. Assumptions and Rationale
9.3. The United States
9.3.1. Total Emergency Department visits for cocaine in US
9.3.2. Emergency Department visits Cocaine Treated cases in US
9.4. EU4 and the UK
9.4.1. Total Emergency Department visits for cocaine in EU4 and the UK
9.4.2. Emergency Department visits Cocaine Treated cases in EU4 and the UK
9.6. Japan
9.6.1. Total Emergency Department visits for cocaine in Japan
9.6.2. Emergency Department visits Cocaine Treated cases in Japan
10. Patient Journey of Cocaine Intoxication
11. Cocaine Intoxication: 7MM Analysis
11.1. Key Findings
11.2. Market Outlook of Cocaine Intoxication
11.3. Key Market Forecast Assumptions
11.3.1. Cost Assumptions
11.3.2. Pricing Trends
11.3.3. Analogue Assessment
11.3.4. Launch Year and Therapy Uptakes
11.4. Conjoint Analysis of Cocaine Intoxication
11.5. Total Market Size of Cocaine Intoxication in the 7MM
11.6. Total Market Size of Cocaine Intoxication by Therapies in the 7MM
11.7. The United States
11.7.1. Total Market Size of Cocaine Intoxication in the United States
11.7.2. Total Market Size of Cocaine Intoxication by Therapies in the United States
11.8. EU4 and the UK
11.8.1. Total Market Size of Cocaine Intoxication in EU4 and the UK
11.8.2. Total Market Size of Cocaine Intoxication by Therapies in EU4 and the UK
11.9. Japan
11.9.1. Total Market Size of Cocaine Intoxication in Japan
11.9.2. Total Market Size of Cocaine Intoxication by Therapies in Japan
12. Unmet Needs of Cocaine Intoxication
13. SWOT Analysis of Cocaine Intoxication
14. KOL Views of Cocaine Intoxication
15. Market Access and Reimbursement of Cocaine Intoxication
15.1. The United States
15.2. EU4 and the UK
15.2.1. Germany
15.2.2. France
15.2.3. Italy
15.2.4. Spain
15.2.5. United Kingdom
15.3. Japan
15.4. Summary and comparison of Market Access and Pricing Policy Developments in 2025
15.5. Market Access and Reimbursement of Cocaine Intoxication Therapies
16. Appendix
16.1. Bibliography
16.2. Report Methodology
List of Tables
Table 1: Summary of Cocaine Intoxication: Market, Epidemiology, and Key Events (2022-2036)
Table 2: Differential Diagnosis of Cocaine Intoxication
Table 3: Total Emergency Department Visits for Cocaine in the 7MM (2022-2036)
Table 4: Emergency Department Visits Cocaine Treated Cases in the 7MM (2022-2036)
Table 5: 7MM Market Size of Cocaine Intoxication by Therapies, in USD Million (2022-2036)
Table 6: The United States Market Size of Cocaine Intoxication by Therapies, in USD Million (2022-2036)
Table 7: EU4 and the UK Market Size of Cocaine Intoxication by Therapies, in USD Million (2022-2036)
Table 8: Japan Market Size of Cocaine Intoxication by Therapies, in USD Million (2022-2036)
List of Figures
Figure 1: Signs and Symptoms of Cocaine Intoxication
Figure 2: Risk Factors of Cocaine Intoxication
Figure 3: Differential Diagnosis of Cocaine Intoxication
Figure 4: Diagnostic Algorithm for Cocaine Intoxication
Figure 5: Treatment Algorithm for Cocaine Intoxication
Figure 6: Treatment Algorithm for Cocaine Intoxication
Figure 7: Total Emergency Department Visits for Cocaine in the 7MM (2022-2036)
Figure 8: Emergency Department Visits Cocaine Treated cases (in the 7MM (2022-2036)
Figure 9: Market Size of Cocaine Intoxication in the 7MM, in USD Million (2022-2036)
Figure 10: 7MM Market Size of Cocaine Intoxication, in USD Million (2022-2036)
For more information about this report visit https://www.researchandmarkets.com/r/xef1z4
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.